Hemab Raises US$ 55M Series A to Advance Next Generation Therapeutics for Bleeding and Thrombosis Disorders

– Benny Sorensen appointed Chief Executive Officer and Co-Founder Johan Henrik Faber appointed Chief Technology Officer
– Financing led by Novo Holdings, HealthCap and RA Capital Management
– Advan… Read full article

Leave a comment

Your email address will not be published. Required fields are marked *